Vir Biotechnology names Brent Sabatini interim principal financial officer as CFO exits

Reuters2026/07/24 12:30

By:Reuters

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Vir Biotechnology named Brent Sabatini interim principal financial officer effective July 23.
Jason O'Byrne will depart to pursue another opportunity, staying through August 3 to support the transition.
Sabatini has served as senior vice president and chief accounting officer since February 2023.
He previously led finance at Capsida Biotherapeutics, following roles at Amgen spanning accounting, tax, FP&A.
A search is underway for a permanent chief financial officer.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vir Biotechnology Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202607240830BIZWIRE_USPR_____20260724_BW933681) on July 24, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Vir Biotechnology names Brent Sabatini interim principal financial officer as CFO exits

You may also like

Crypto prices